Health Services · Hospital/Nursing Management · NSE: INDRAMEDCO · data 2026-10-09
Indraprastha Medical Corporation Limited
Health check: Strong (6.8/10 on quality, valuation vs sector, growth and momentum).
Open full analysis — chart, results, balance sheet, red flags →Key figures
Price
₹329.05
Market cap
₹2,933 cr
P/E
16
P/B
—
ROE
27.5%
ROCE
30.0%
Debt / equity
0.05
Dividend yield
1.25%
1-year return
-40.5%
52-week high
₹640.85
52-week low
₹317.15
Operating margin
15.0%
Growth
| Revenue (last 12 months) | ₹1,524 cr |
| Net profit (last 12 months) | ₹188 cr |
| Sales growth, 3 years (yearly) | 10.5% |
| Profit growth, 3 years (yearly) | 28.7% |
Similar companies
Kovai Medical Center & Hospital Ltd. (KOVAI) · Artemis Medicare Services Ltd. (ARTEMISMED) · KMC Speciality Hospitals (India) Limited (KMCSHIL) · Gujarat Kidney & Super Speciality Ltd. (GKSL) · Shalby Ltd. (SHALBY)
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open INDRAMEDCO in NSE Scanner →